Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Optic nerve cell protection encompasses a set of molecular targets—including anti-apoptotic pathways (CREB/BCL‑2), trophic factor signaling (BDNF), stress response elements (HSF‑regulated OSK)—that together aim to preserve or restore retinal ganglion cells after insult. These targets are under active investigation as therapeutic entry points for preventing irreversible vision loss from various forms of optic neuropathy.
Various, including: activation of CREB/BCL-2 pathway, neurotrophic factor support, modulation of apoptosis, induction of pluripotency factors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Optic Nerve Cell Protection.